Vol 4, No 3 (June 28, 2015): Translational Andrology and Urology (Urological Oncology)

Preface

Focused issue on urological oncology
George N. Thalmann
Translational Andrology and Urology  
2015;
4
(3)
:243
.

Review Article

Bacille-Calmette-Guerin non-responders: how to manage
Friedrich-Carl von Rundstedt, Seth P. Lerner
Translational Andrology and Urology  
2015;
4
(3)
:244-253
.
Standard cystectomy fits all: truth or myth?
Beat Roth, George N. Thalmann
Translational Andrology and Urology  
2015;
4
(3)
:254-260
.
Upper urinary tract disease: what we know today and unmet needs
Romain Mathieu, Karim Bensalah, Ilaria Lucca, Aurélie Mbeutcha, Morgan Rouprêt, Shahrokh F. Shariat
Translational Andrology and Urology  
2015;
4
(3)
:261-272
.
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
Isuru S. Jayaratna, Neema Navai, Colin P. N. Dinney
Translational Andrology and Urology  
2015;
4
(3)
:273-282
.
Indications for biopsy and the current status of focal therapy for renal tumours
Ricardo R.N. Leão, Patrick O. Richard, Michael A.S. Jewett
Translational Andrology and Urology  
2015;
4
(3)
:283-293
.
Outlining the limits of partial nephrectomy
Sameer Chopra, Raj Satkunasivam, Chandan Kundavaram, Gangning Liang, Inderbir S. Gill
Translational Andrology and Urology  
2015;
4
(3)
:294-300
.
Cytoreductive surgery in the era of targeted molecular therapy
Arun Z. Thomas, Mehrad Adibi, Leonardo D. Borregales, Jose A. Karam, Christopher G. Wood
Translational Andrology and Urology  
2015;
4
(3)
:301-309
.
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
Stefanie Fischer, Silke Gillessen, Christian Rothermundt
Translational Andrology and Urology  
2015;
4
(3)
:310-325
.
The current and future role of magnetic resonance imaging in prostate cancer detection and management
Jan Philipp Radtke, Dogu Teber, Markus Hohenfellner, Boris A. Hadaschik
Translational Andrology and Urology  
2015;
4
(3)
:326-341
.
Active surveillance and focal therapy for low-intermediate risk prostate cancer
Laurence Klotz
Translational Andrology and Urology  
2015;
4
(3)
:342-354
.
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
Federica Recine, Cora N. Sternberg
Translational Andrology and Urology  
2015;
4
(3)
:355-364
.
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Thenappan Chandrasekar, Joy C. Yang, Allen C. Gao, Christopher P. Evans
Translational Andrology and Urology  
2015;
4
(3)
:365-380
.
Advances in the treatment of testicular cancer
Yaron Ehrlich, David Margel, Marc Alan Lubin, Jack Baniel
Translational Andrology and Urology  
2015;
4
(3)
:381-390
.

Disclosure:

The focused issue “Urological Oncology” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. George N. Thalmann served as the unpaid Guest Editor for the focused issue.